Flagship Ventures Opportunities Fund I, L.p. - Net Worth and Insider Trading

Flagship Ventures Opportunities Fund I, L.p. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Flagship Ventures Opportunities Fund I, L.p. owns 5 companies in total, including Foghorn Therapeutics Inc (FHTX) , Evelo Biosciences Inc (EVLO) , and Kaleido Biosciences Inc (KLDO) among others .

Click here to see the complete history of Flagship Ventures Opportunities Fund I, L.p.’s form 4 insider trades.

Insider Ownership Summary of Flagship Ventures Opportunities Fund I, L.p.

Ticker Comapny Transaction Date Type of Owner
FHTX Foghorn Therapeutics Inc 2020-10-22 10 percent owner
EVLO Evelo Biosciences Inc 2018-05-08 10 percent owner
KLDO Kaleido Biosciences Inc 2019-02-27 10 percent owner
LIMIT LIMIT 2020-05-18 10 percent owner
LIMIT LIMIT 2021-03-19 10 percent owner

Flagship Ventures Opportunities Fund I, L.p. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Flagship Ventures Opportunities Fund I, L.p. Ownership Network

Ownership Network List of Flagship Ventures Opportunities Fund I, L.p.

No Data

Ownership Network Relation of Flagship Ventures Opportunities Fund I, L.p.

Insider Network Chart

Flagship Ventures Opportunities Fund I, L.p. Owned Company Details

What does Foghorn Therapeutics Inc do?

Who are the key executives at Foghorn Therapeutics Inc?

Flagship Ventures Opportunities Fund I, L.p. is the 10 percent owner of Foghorn Therapeutics Inc. Other key executives at Foghorn Therapeutics Inc include Chief People Officer Carlos Costa , See Remarks Steven F. Bellon , and Chief Strategy/Bus Ops Officer Fanny Cavalie .

Foghorn Therapeutics Inc (FHTX) Insider Trades Summary

Over the past 18 months, Flagship Ventures Opportunities Fund I, L.p. made no insider transaction in Foghorn Therapeutics Inc (FHTX). Other recent insider transactions involving Foghorn Therapeutics Inc (FHTX) include a net sale of 311,297 shares made by Samuel Agresta , a net sale of 20,000 shares made by Steven F. Bellon , and a net sale of 11,000 shares made by Fanny Cavalie .

In summary, during the past 3 months, insiders sold 30,672 shares of Foghorn Therapeutics Inc (FHTX) in total and bought 0 shares, with a net sale of 30,672 shares. During the past 18 months, 352,969 shares of Foghorn Therapeutics Inc (FHTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 352,969 shares.

Foghorn Therapeutics Inc (FHTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Foghorn Therapeutics Inc Insider Transactions

No Available Data

Flagship Ventures Opportunities Fund I, L.p. Mailing Address

Above is the net worth, insider trading, and ownership report for Flagship Ventures Opportunities Fund I, L.p.. You might contact Flagship Ventures Opportunities Fund I, L.p. via mailing address: One Memorial Drive, 7th Floor, Cambridge Ma 02142.

Discussions on Flagship Ventures Opportunities Fund I, L.p.

No discussions yet.